Mandate

Vinge is advising Atairos in connection with its $580 million recommended acquisition of the entire issued and to be issued share capital of Ocean Outdoor it does not already own

May 06, 2022 M&A

The transaction will be implemented by way of a statutory merger under BVI law, subject to anti-trust approval in Sweden and other customary approvals and conditions. It is expected that the merger will become effective in June 2022.

Atairos is an independent private company focused on supporting growth-oriented businesses across a wide range of industries. Atairos has approximately $6.5 billion in equity capital and offices in New York City, London and Philadelphia. Ocean Outdoor is a leading operator of digital out-of-home (DOOH) advertising across the United Kingdom, Northern and Continental Europe. Ocean's network of 4,000+ screens covers seven countries and 351 cities with its technological capabilities delivering the most impactful and measurable DOOH brand and advertising experiences. Ocean's portfolio comprises of some of the most iconic locations, such as the Piccadilly Lights and the BFI IMAX. Ocean’s ordinary shares are traded on the Main Market of the London Stock Exchange.

Vinge's team primarily consisted of Sofie Nordgren (Counsel, M&A), Pär Remnelid (Partner, EU / Competition) and Carl Trolle Olson (Associate, M&A).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025